Analyst firms · Barclays · HCA

Barclays HCA price target and rating history

HCA Healthcare Inc. (HCA) · Health Care

Barclays rates HCA Healthcare Inc. (HCA) Equal Weight with a $427 price target, as of its latest action on Jul 8, 2026. It has published 4 rating actions on HCA since July 2021, including 0 upgrades and 2 downgrades. Across 3 firms with a HCA price target in the last 12 months, the median target is $427. Barclays's target matches it.

Current rating
Equal Weight
Price target
$427
Median target, all firms
$427
Actions on HCA
4

Barclays price target on HCA

$427$347$26720222023202420252026
Barclays price target on HCA, each point a stated target, July 2021 to July 2026.

Every Barclays rating on HCA

How other firms rate HCA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BMO Capital MarketsOutperform$495Sep 23, 2026
BarclaysEqual Weight$427Jul 8, 2026
Morgan StanleyUnderweight$425Dec 15, 2025

Questions about Barclays and HCA

What is Barclays's price target for HCA?
Barclays's latest stated price target for HCA Healthcare Inc. (HCA) is $427, from its action on Jul 8, 2026.
What is Barclays's rating on HCA?
Barclays rates HCA Equal Weight, a neutral rating, as of Jul 8, 2026.
When did Barclays last change its view on HCA?
On Jul 8, 2026, Barclays downgrades to Equal Weight from Overweight, price target $427.
How does Barclays's HCA target compare with other analysts?
Across 3 firms with a HCA price target in the last 12 months, the median target is $427. Barclays's target matches it.

More HCA rating histories

All Barclays ratingsHCA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.